Differentiation of Macrophage Precursors to Cells with LAK Activity under the Influence of CSF-1 and High Dose IL-2
- 1 May 1991
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 33 (5) , 511-520
- https://doi.org/10.1111/j.1365-3083.1991.tb02521.x
Abstract
Mouse macrophage precursor cells with natural killer (NK) like activity, derived from in vitro culture of light-fraction-bone marrow cells in the presence of colony-stimulating factor 1 (CSF-1) and low dose IL-2, were incubated with high dose (1000 U/ml) IL-2. After 3 days of incubation, cells had developed from NK like (killing Yac-1 but not P815) into LAK-like (killing both YAC-1 and P815) effector cells. Morphological studies revealed that LAK activity occurred at the time when macrophage precursors with NK like activity containing few cytoplasmic granules had further differentiated into cells with abundant azurophilic granules in their cytoplasma. Proliferation of macrophage-precursor derived NK/LAK-like cells was dependent on the presence of colony-stimulating factor, generation of cytoplasmic granules was induced by IL-2 in a dose dependent way. Flow cytometric analysis showed that macrophage precursor-derived LAK effectors were positive for NK 1.1 but almost negative for F4/80. When the same starting cell population was cultured in the presence of 200 U/ml Interferon gamma (IFN gamma), proliferation was completely stopped and within 3-4 days all cells differentiated into mature macrophages expressing F4/80. In context with our previous data, we describe here a continuum of development from agranular macrophage precursors to granular cells with NK-like activity and further to cells with LAK activity under the influence of CSF-1 as growth factor and IL-2 as granule- and cytotoxicity-inducing factor.Keywords
This publication has 16 references indexed in Scilit:
- Murine macrophage precursor characterization. I. Production, phenotype and differentiation of macrophage precursor hybridsEuropean Journal of Immunology, 1990
- Cooperative effects of colony-stimulating factor 1 and recombinant interleukin 2 on proliferation and induction of cytotoxicity of macrophage precursors generated from mouse bone marrow cell cultures.The Journal of Experimental Medicine, 1989
- Production of hematopoietic colony-stimulating factors by human natural killer cells.The Journal of Experimental Medicine, 1989
- Toxicity and therapeutic efficacy of high-dose interleukin 2. In vivo infusion of antibody to NK-1.1 attenuates toxicity without compromising efficacy against murine leukemia.The Journal of Experimental Medicine, 1989
- Lymphokine-activated killer cell activity: Characteristics of effector cells and their progenitors in blood and spleenImmunology Today, 1987
- Functional heterogeneity of murine macrophage precursor cells from spleen and bone marrowCellular Immunology, 1986
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.Journal of Clinical Investigation, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Expression of the macrophage-specific antigen F4/80 during differentiation of mouse bone marrow cells in culture.The Journal of Experimental Medicine, 1981
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981